Number of the records: 1  

Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE

  1. TitleLong-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
    Author infoP. Schöffski, Kubickova M. ... [et al.]
    Co-authors Schöffski P.
    Kubičková Michaela
    Corporation Redakcia Onkológia
    NoteEuropean Journal of Cancer, vol. 156 (2021), s. 12-23
    Sign.C 3069
    Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2022 . - Roč. 17, č. 1 (2022), s. 68
    MeSH Subject sarkóm
    kináza anaplastického lymfómu
    skúšanie klinické, fáza II, ako téma
    výsledok liečby
    Form, Genre abstrakt v angličtine
    Subj. Headings nádory inflamatórne myofibroblastické * krizotinib
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.